Jennifer Vasquez, NP
Adult Health · Patchogue, NYNPI 1134890254
Payments from drug & device makers
Across 54 payments — averaging $52.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$829
- Neurocrine Biosciences, Inc.$319
- AbbVie$228
- Biogen$220
- Boston Scientific$153
- Abbott$150
- plus $952 from 16 others
What the payments were for
- Travel & lodging$36113%
- Food & beverage$2,44586%
- Education$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $829 |
| Neurocrine Biosciences, Inc. | 6 | $319 |
| AbbVie | 7 | $228 |
| Biogen | 3 | $220 |
| Boston Scientific | 2 | $153 |
| Abbott | 2 | $150 |
| Sanofi | 2 | $149 |
| Acadia Pharmaceuticals Inc | 3 | $136 |
| CSL Behring | 1 | $125 |
| Tris Pharma Inc | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| Amneal Pharmaceuticals LLC | 4 | $61 |
| Tolmar, Inc. | 2 | $38 |
| Merz Pharmaceuticals, LLC | 1 | $36 |
| Neurelis, Inc. | 1 | $29 |
| Amgen | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Tanabe Pharma America, Inc. | 1 | $19 |
| Corium, LLC | 1 | $19 |
| Pfizer | 1 | $19 |
| Almatica Pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PERCEPT PC BRAINSENSE$691
- INGREZZA$218
- WATCHMAN FLX$134
- Hizentra$125
- Quillichew ER$125
- Quillivant$125
- Dyanavel XR$125
- Leqembi$122
- UBRELVY$122
- NUPLAZID$120
How this compares
$2,850 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 151 | $2,090,475 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 44 | $1,004,044 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 14 | $366,614 |
| BotoxOnabotulinumtoxina | 117 | $141,597 |
| AustedoDeutetrabenazine | 21 | $115,024 |
| NuplazidPimavanserin Tartrate | 21 | $99,764 |
| RexultiBrexpiprazole | 50 | $76,838 |
| NeuproRotigotine | 83 | $75,287 |
| NourianzIstradefylline | 21 | $72,889 |
| AptiomEslicarbazepine Acetate | 29 | $71,889 |
| GocovriAmantadine Hcl | 16 | $54,652 |
| UbrelvyUbrogepant | 31 | $51,517 |
| QuliptaAtogepant | 35 | $45,213 |
| OxycontinOxycodone Hcl | 65 | $40,093 |
| OngentysOpicapone | 48 | $36,681 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringPrivigen | $125 | $366,61414 claims |
| AbbVieBotox, Ubrelvy, Qulipta, Linzess, Namzaric | $228 | $260,025206 claims |
| Acadia Pharmaceuticals IncNuplazid | $136 | $99,76421 claims |
| Neurocrine Biosciences, Inc.Ongentys | $319 | $36,68148 claims |
| PfizerNurtec Odt | $19 | $28,00717 claims |
| Amneal Pharmaceuticals LLCRytary | $61 | $21,99135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.
Other adult health in Patchogue
- Laura BuckPatchogue$20K
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.